Hello, everyone, and welcome to the working week. We hope the weekend was invigorating and restored your willpower to tackle another demanding few days of meetings and deadlines. To cope with our own schedule, we are brewing our usual elixir - a delicious cup of stimulation. Please join us. And now, the fun begins. So, here are a few items to get you started. Hope your day goes well and you meet all your challenges...
Pakistan Seals Factory Where Meds Killed 28 People (The Nation)
Biogen & Elan Win Label Change For Tysabri & Specific Patients (Bloomberg News)
BioMarin And Its $400,000 Dwarfism Medicine Offers Hope (Bloomberg News)
Drugmakers Brace For Settlements Into Corruption Probes (Financial Times)
A Marijuana-Based Prescription Spray For Cancer Pain (Associated Press)
Should Healthy People Take Statins? (Wall Street Journal)
EMA Says Using Subcontractors Strains GCP Compliance (Outsourcing Pharma)
Biotechs Cut Biosimilar Deals (Investor's Business Daily)
EMA Revises Active Substance Guidelines (InPharma Technologist)
EDITOR'S NOTE: Please check this post for updates throughout the morning